Product Image

Monolaurin 600 mg

Ecological Formulas
4.8
★ ★ ★ ★ ★
(1820 ratings)
Monolaurin 600 mg
Product Image
Score80
A practical 600 mg capsule combines solid strength with good value. Incomplete form and source disclosure is the main weakness.
How scoring works
Quantity:90 Capsule(s) • (90 servings)
Goals:
Immunity

Score 80

A practical 600 mg capsule combines solid strength with good value. Incomplete form and source disclosure is the main weakness.
How scoring works
$23.96($0.26 per serving)
iHerb
$ 26.40
Pure Formulas
$ 23.96
Amazon
$ 28.00
Report prices

Analysis

A 600 mg monolaurin amount provides a stronger single-capsule serving than many entry-level products. The one-active formula is direct and makes the intended use easy to understand.

The label states the active weight but not whether it is glycerol monolaurate or where it comes from. Those omissions limit ingredient transparency even though the serving quantity itself is clear.

Favorable value and a one-capsule serving make it practical for people who specifically want monolaurin. Its contribution remains narrow because it does not address broader vitamin, mineral, antioxidant, or barrier-support pathways.

Who is it for
  • Adults seeking a mid-to-high monolaurin amount
  • People who prefer one active per capsule
  • Value-conscious users wanting simple dosing
Best for
  • A 600 mg single-capsule serving
  • Focused monolaurin use
  • Balancing amount and value

Pros

  • Provides 600 mg in one capsule
  • Simple formula is easy to assess
  • Favorable value for the amount

Cons

  • Does not identify glycerol monolaurate
  • Source material is not stated
  • Narrow formula lacks broader nutritional support

Nutrient quality

84 Highest impact

A meaningful standalone amount provides a strong dose foundation. Missing ester and source details keep form quality uncertain.

.

Ingredient transparency

75 High impact

Active amounts are listed and no proprietary blend hides the supplied doses. Missing complete directions, excipients, and some source or standardization details keep disclosure incomplete.

.

Customer satisfaction

72 High impact

The supplied average is excellent and backed by a very large review base. Specific review comments were not provided, so repeated complaints and purpose-specific experiences cannot be assessed.

.

Value for money

91 Highest impact

A meaningful amount and favorable serving cost create strong value. Incomplete form and source disclosure remain the main trade-offs.

.
Report analysis

Goals

Immunity
Impact
Moderate effect
D Goal FitB- Strength of SupportD CoverageA Formula Quality
Monolaurin · 600 mg

Monolaurin at 600 mg provides a substantial single-capsule amount with plausible antimicrobial activity. The active weight is fully disclosed and the formula stays focused.

Human evidence for meaningful immune outcomes remains limited, and the label does not identify glyceryl monolaurate or source material. Major barrier, vitamin, mineral, and antioxidant pathways are not addressed.

Study evidence
Monolaurin Not classified 1 study

Ingredients

IngredientAmount per serving
Monolaurin
600 mg
Adults 18–50
Report overview
Monolaurin · 600 mg OverallScore73
C- Active Ingredient Quality & BioavailabilityA Dose, Safety & Label TransparencyB Value

The formula clearly discloses a strong 600 mg monolaurin serving in one capsule. Form quality remains uncertain because the label does not specify glyceryl monolaurate or a coconut source. Cost efficiency is favorable for the amount delivered.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Reduction in Staphylococcus aureus growth and exotoxin production and in vaginal interleukin 8 levels due to glycerol monolaurate in tampons
    Kristi L Strandberg, Marnie L Peterson, Matthew M Schaefers, Laura C Case, Melinda C Pack, David J Chase, Patrick M Schlievert · Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2009
    Randomized trial225 participantsImmunity forMonolaurin